These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17049532)

  • 1. The role of C-reactive protein as a marker for cardiovascular risk associated with antiretroviral therapy in HIV-infected patients.
    Masiá M; Bernal E; Padilla S; Graells ML; Jarrín I; Almenar MV; Molina J; Hernández I; Gutiérrez F
    Atherosclerosis; 2007 Nov; 195(1):167-71. PubMed ID: 17049532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
    Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity C-reactive protein levels in HIV-infected patients treated or not with antiretroviral drugs and their correlation with factors related to cardiovascular risk and HIV infection.
    Guimarães MM; Greco DB; Figueiredo SM; Fóscolo RB; Oliveira AR; Machado LJ
    Atherosclerosis; 2008 Dec; 201(2):434-9. PubMed ID: 18359028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men.
    Floris-Moore M; Howard AA; Lo Y; Schoenbaum EE; Arnsten JH; Klein RS
    AIDS Patient Care STDS; 2007 Jul; 21(7):479-91. PubMed ID: 17651029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric dimethylarginine concentrations decrease in patients with HIV infection under antiretroviral therapy.
    Kurz K; Teerlink T; Sarcletti M; Weiss G; Zangerle R; Fuchs D
    Antivir Ther; 2012; 17(6):1021-7. PubMed ID: 22892398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of metabolic and inflammatory markers in HIV infection: glucose, lipids, serum Hs-CRP and myeloperoxidase.
    Borato DC; Parabocz GC; Ribas SR; Kalva-Filho CA; Borba LM; Ito CA; Bail L; dos Santos FA; Vellosa JC
    Metabolism; 2012 Oct; 61(10):1353-60. PubMed ID: 22480983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between C-reactive protein, pro-oxidant-antioxidant balance and traditional cardiovascular risk factors in an Iranian population.
    Razavi A; Baghshani MR; Rahsepar AA; Mohaddes Ardabili H; Sheikh Andalibi MS; Reza Parizadeh SM; Tavallaie S; Mousavi S; Ghayour-Mobarhan M; Ferns G
    Ann Clin Biochem; 2013 Mar; 50(Pt 2):115-21. PubMed ID: 23440541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-treatment C-reactive protein and HDL cholesterol levels in patients at intermediate cardiovascular risk: impact on carotid intima-media thickness.
    Pirro M; Vaudo G; Lupattelli G; Pasqualini L; Mannarino MR; Schillaci G; Alaeddin A; Paciullo F; Fallarino F; Bagaglia F; Mannarino E
    Life Sci; 2013 Sep; 93(8):338-43. PubMed ID: 23871987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART.
    Berg T; Zdunek D; Stalke J; Dupke S; Baumgarten A; Carganico A; Hess G
    Eur J Med Res; 2007 Apr; 12(4):152-60. PubMed ID: 17509959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients.
    Bastard JP; Soulié C; Fellahi S; Haïm-Boukobza S; Simon A; Katlama C; Calvez V; Marcelin AG; Capeau J
    Antivir Ther; 2012; 17(5):915-9. PubMed ID: 22436412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cardiovascular events predicted by the Rama-EGAT score among HIV-infected patients in Thailand.
    Suppadungsuk S; Yamwong S; Sungkanuparph S
    Southeast Asian J Trop Med Public Health; 2013 Sep; 44(5):818-24. PubMed ID: 24437317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
    Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
    Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
    Ridker PM; Hennekens CH; Buring JE; Rifai N
    N Engl J Med; 2000 Mar; 342(12):836-43. PubMed ID: 10733371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and determinants of serum high-sensitive C-reactive protein in a population of young adults: The Cardiovascular Risk in Young Finns Study.
    Raitakari M; Mansikkaniemi K; Marniemi J; Viikari JS; Raitakari OT
    J Intern Med; 2005 Nov; 258(5):428-34. PubMed ID: 16238678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women.
    Floris-Moore M; Howard AA; Lo Y; Arnsten JH; Santoro N; Schoenbaum EE
    HIV Med; 2006 Oct; 7(7):421-30. PubMed ID: 16925727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [C-reactive protein levels determined by an ultrasensitive method in a healthy Hungarian population].
    Dósa E; Szabó A; Entz L; Selmeci L; Walentin S; Kleiber M; Rugonfalvi KS; Hosszúfalusi N; Füst G; Prohászka Z
    Orv Hetil; 2004 Mar; 145(11):567-72. PubMed ID: 15098505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of inflammatory cytokines and endothelial adhesion molecules with immunological, virological, and cardiometabolic disease in HIV-infected individuals.
    Lacerda HR; Falcão Mda C; de Albuquerque VM; Zírpoli JC; Miranda-Filho Dde B; de Albuquerque Mde F; Montarroyos U; Ximenes RA
    J Interferon Cytokine Res; 2014 May; 34(5):385-93. PubMed ID: 24359573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of cardiovascular risk factors and serum ferritin with C-reactive protein.
    Sung KC; Kang JH; Shin HS
    Arch Med Res; 2007 Jan; 38(1):121-5. PubMed ID: 17174735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short communication: contribution of the immunovirological state and traditional cardiovascular risk factors to low HDL-cholesterol in HIV patients.
    Palacios R; Puerta S; Orihuela F; Olalla J; Roldán J; Grana M; Márquez M; Colmenero JD; Santos J;
    AIDS Res Hum Retroviruses; 2010 Nov; 26(11):1167-70. PubMed ID: 20929391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
    Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
    Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.